Immunic (IMUX) announced the appointment of Michael Bonney as chair of its board of directors, effective May 16. Simona Skerjanec will transition from interim chairperson to continue serving as a member of the board. During his tenure at Biogen (BIIB), he held senior commercial leadership roles.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMUX: